Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 18/20 | 0.45 |
| ▸ | DRD2 | P14416 | 13/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 13/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | MOGAT2 | Q3SYC2 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4392647 | 0.90 | DRD3 (0.43) | DRD3DRD2KCNH2 | |
| SCHEMBL4383336 | 0.89 | DRD3 (0.46) | DRD3DRD2KCNH2HRH1 | |
| SCHEMBL4388088 | 0.88 | DRD3 (0.55) | DRD3DRD2KCNH2HRH1 | |
| SCHEMBL4381511 | 0.86 | DRD3 (0.46) | DRD3DRD2KCNH2HRH1 | |
| SCHEMBL4384725 | 0.84 | DRD3 (0.47) | DRD3DRD2KCNH2HRH1 | |
| SCHEMBL4386426 | 0.83 | DRD3 (0.51) | DRD3DRD2KCNH2HRH1 | |
| SCHEMBL4384802 | 0.83 | DRD3 (0.54) | DRD3DRD2KCNH2 | |
| SCHEMBL4382325 | 0.80 | DRD3 (0.53) | DRD3DRD2KCNH2HRH1 | |
| SCHEMBL4387200 | 0.76 | DRD3 (0.58) | DRD3DRD2KCNH2HRH1 | |
| SCHEMBL4392618 | 0.76 | DRD3 (0.57) | DRD3DRD2KCNH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1144405-B1 | TRIAZOLE COMPOUNDS WITH DOPAMINE-D3-RECEPTOR AFFINITY | ABBOTT GMBH & CO KG (DE) | 2009-11-25 | — | — | EP | disclosed |
| US-6602867-B1 | Triazole compounds with dopamine-D3-receptor affinity | ABBOTT LABORATORIES | 2003-08-05 | — | — | US | disclosed |